EFFECTS OF CPAP ON DAYTIME FUNCTIONS The Effect of CPAP in Normalizing Daytime Sleepiness , Quality of Life , and Neurocognitive Function in Patients with Moderate to Severe OSA

111 The Effect of CPAP on Neurobehavior in OSA—Antic et al CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) HAS BEEN SHOWN TO REDUCE DAYTIME SLEEPINESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA (OSA) and is widely accepted as the most efficacious therapy for OSA. Patel and colleagues performed a meta-analysis showing that CPAP reduced the Epworth Sleepiness Scale (ESS) score an average of 2.9 points more than did placebo (P < 0.001) in patients with OSA. Patients with moderate to severe OSA had a greater fall in ESS than did those with mild OSA.1 What is less well understood is the dose-response relationship of CPAP treatment in patients with OSA and the proportion of patients who return to normal neurobehavioral function after CPAP therapy. These are important questions because it is known that CPAP adherence varies widely among patients.2 For example, in an early study, Weaver et al. reported that, among 32 patients using CPAP, half were consistent users, applying CPAP on more than 90% of nights for an average of 6.2 hours per night, whereas the other half were intermittent users who had a wide range of daily use, averaging 3.5 hours per night.3 In addition, although many patients present with excessive daytime sleepiness (EDS), this is a relatively nonspecific symptom.4 In the Sleep Heart Health study, the percentage of subjects with EDS, defined as an ESS score greater than 10, was increased from 21% in subjects with an AHI of less than 5 to 35% in those with an AHI of at least 30. Thus, many people without OSA were still subjectively reporting EDS.5 It is likely that, in a proportion of patients with OSA, sleep apnea may not be the dominant cause of sleepiness, and, thus, CPAP therapy may only partially improve EDS. In a population-based study, Bixler and colleagues6 found that depression was the most significant risk factor for EDS, followed by, in decreasing levels of importance, body mass index, age, typical sleep duration, diabetes, smoking, and finally OSA. The same group noted in an earlier study that obesity itself may be associated with EDS independent of OSA.7-9 Finally, recent evidence suggests that OSA may lead to permanent structural brain abnormalities.9,10 If these abnormalities EFFECTS OF CPAP ON DAYTIME FUNCTIONS

[1]  A. Esterman,et al.  A randomized controlled trial of nurse-led care for symptomatic moderate-severe obstructive sleep apnea. , 2009, American journal of respiratory and critical care medicine.

[2]  Ronald R Grunstein,et al.  Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. , 2008, Proceedings of the American Thoracic Society.

[3]  J. Santamaria,et al.  Persistent sleepiness in CPAP treated obstructive sleep apnea patients: evaluation and treatment. , 2007, Sleep medicine reviews.

[4]  Greg Maislin,et al.  Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. , 2007, Sleep.

[5]  R. Millman,et al.  Normalization of memory performance and positive airway pressure adherence in memory-impaired patients with obstructive sleep apnea. , 2006, Chest.

[6]  G. Pillar,et al.  The 20-min trial of the Maintenance of Wakefulness Test is profoundly affected by motivation , 2006, Sleep and Breathing.

[7]  T. Morgenthaler,et al.  Complex sleep apnea syndrome: is it a unique clinical syndrome? , 2006, Sleep.

[8]  W. Kohler,et al.  Symptoms of depression in individuals with obstructive sleep apnea may be amenable to treatment with continuous positive airway pressure. , 2005, Chest.

[9]  E. Bixler,et al.  Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. , 2005, The Journal of clinical endocrinology and metabolism.

[10]  E. Bixler,et al.  Sleep apnea is a manifestation of the metabolic syndrome. , 2005, Sleep medicine reviews.

[11]  E. Gordon,et al.  Integrative Neuroscience: The Role of a Standardized Database , 2005, Clinical EEG and neuroscience.

[12]  E. Gordon,et al.  The dose-dependent effect of methylphenidate on performance, cognition and psychophysiology. , 2005, Journal of integrative neuroscience.

[13]  Jennifer D. Davis,et al.  Neuropsychological sequelae of obstructive sleep apnea-hypopnea syndrome: A critical review , 2004, Journal of the International Neuropsychological Society.

[14]  S. Banks,et al.  The maintenance of wakefulness test in normal healthy subjects. , 2004, Sleep.

[15]  D. Praticò,et al.  Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions. , 2004, Sleep.

[16]  Mary J Morrell,et al.  Changes in brain morphology associated with obstructive sleep apnea. , 2003, Sleep medicine.

[17]  D. Beebe,et al.  The neuropsychological effects of obstructive sleep apnea: a meta-analysis of norm-referenced and case-controlled data. , 2003, Sleep.

[18]  Shao-guang Huang,et al.  [Prevalence of obstructive sleep apnea-hypopnea syndrome in Chinese adults aged over 30 yr in Shanghai]. , 2003, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[19]  R. Chervin Epworth sleepiness scale? , 2003, Sleep medicine.

[20]  A. Malhotra,et al.  Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. , 2003, Archives of internal medicine.

[21]  Jeffry R Alger,et al.  Brain morphology associated with obstructive sleep apnea. , 2002, American journal of respiratory and critical care medicine.

[22]  F. J. Nieto,et al.  The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study. , 2001, Sleep.

[23]  Daniel J Buysse,et al.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. , 1999, Sleep.

[24]  Crispin Jenkinson,et al.  Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial , 1999, The Lancet.

[25]  A I Pack,et al.  An instrument to measure functional status outcomes for disorders of excessive sleepiness. , 1997, Sleep.

[26]  J. Stradling,et al.  Comparison of three measures of quality of life outcome in the evaluation of continuous positive airways pressure therapy for sleep apnoea , 1997, Journal of sleep research.

[27]  A I Pack,et al.  Night-to-night variability in CPAP use over the first three months of treatment. , 1997, Sleep.

[28]  M. Johns,et al.  Reliability and factor analysis of the Epworth Sleepiness Scale. , 1992, Sleep.

[29]  M. Johns,et al.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale. , 1991, Sleep.

[30]  E. Vieth Fitting piecewise linear regression functions to biological responses. , 1989, Journal of applied physiology.

[31]  E. Wolpert A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. , 1969 .

[32]  D. Hudgel,et al.  Comparison between automatic and fixed positive airway pressure therapy in the home. , 2003, American journal of respiratory and critical care medicine.

[33]  F. J. Nieto,et al.  Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. , 1999, American journal of respiratory and critical care medicine.

[34]  C. Guilleminault,et al.  EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. , 1992, Sleep.